India to Sri Lanka: Adalimumab Export Trade Route
India has recorded 4 verified shipments of Adalimumab exported to Sri Lanka, representing a combined trade value of $238.3K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $59.6K USD. The leading Indian exporter is RELIANCE LIFE SCIENCES PRIVATE LIMITED, which accounts for 99% of total export value with 2 shipments worth $234.9K USD. On the buying side, BANK OF CEYLON - TRADE SERVICES - C is the largest importer in Sri Lanka with $227.7K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Sri Lanka Adalimumab corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $238.3K USD. The route is dominated by RELIANCE LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's adalimumab manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $59.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with adalimumab's non-urgent bulk-order profile.
Shipment activity peaks during October-December, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 14.1%, placing it at rank #2 among India's top adalimumab export destinations globally.
On the import side, key buyers of Indian adalimumab in Sri Lanka include BANK OF CEYLON - TRADE SERVICES - C, ABC PHARMA SERVICES (PVT) LTD, INDIRA MADRI ABEYRATNE RATWATTE. BANK OF CEYLON - TRADE SERVICES - C is the single largest importer with 1 shipments valued at $227.7K USD.
